French vaccine maker Valneva said on May 13 it is planning to lay off 10 to 15 percent of its workforce, due to declining uptake of vaccines for travel.
Valneva said in a statement that its outlook has been impacted by “an emerging adverse trend in travel vaccine uptake across key markets, driven by geopolitical factors.”
